Citations

Clear

116 citation(s) found for "Colby, Thomas".

Usual Interstitial Pneumonia Can Be Detected in Transbronchial Biopsies Using Machine Learning
Pankratz, Daniel G., Choi, Yoonha, Imtiaz, Urooj, Fedorowicz, Grazyna, Anderson, Jessica, Colby, Thomas V. , Lynch, David A. , Brown, Kevin K. , Flaherty, Kevin R. , Steele, Mark P., Groshong, Steve D. , Raghu, Ganesh , Barth, Neil M., Walsh, P. Sean, Huang, Jing , Kennedy, Giulia C., Myers, Jeffrey L. , Martínez, Fernando J.

Mayo Clinic

Annals of the American Thoracic Society | June 22, 2017 | Volume: 14 | Issue: 11 | Pages: 1646-1654

10.1513/annalsats.201612-947oc | PMID 28640655 Get It

Abstract Rationale Usual interstitial pneumonia (UIP) is the histopathologic hallmark of idiopathic pulmonary fibrosis. Although UIP can be detected by high-resolution computed tomography of the chest, the results are frequently inconclusive, and pathology from transbronchial biopsy (TBB) has poor sensitivity. Surgical lung biopsy may be necessary for a definitive diagnosis. Objectives To develop a genomic classifier in tissue obtained by TBB that distinguishes UIP from non-UIP, trained against central pathology as the reference standard. Methods Exome enriched RNA sequencing was performed on 283 TBBs from 84 subjects. Machine learning was used to train an algorithm with high rule-in (specificity) performance using specimens from 53 subjects. Performance was evaluated by cross-validation and on an independent test set of specimens from 31 subjects. We explored the feasibility of a single molecular test per subject by combining multiple TBBs from upper and lower lobes. To address whether classifier accuracy depends upon adequate alveolar sampling, we tested for correlation between classifier accuracy and expression of alveolar-specific genes. Results The top-performing algorithm distinguishes UIP from non-UIP conditions in single TBB samples with an area under the receiver operator characteristic curve (AUC) of 0.86, with specificity of 86% (confidence interval = 71–95%) and sensitivity of 63% (confidence interval = 51–74%) (31 test subjects). Performance improves to an AUC of 0.92 when three to five TBB samples per subject are combined at the RNA level for testing. Although we observed a wide range of type I and II alveolar–specific gene expression in TBBs, expression of these transcripts did not correlate with classifier accuracy. Conclusions We demonstrate proof of principle that genomic analysis and machine learning improves the utility of TBB for the diagnosis of UIP, with greater sensitivity and specificity than pathology in TBB alone. Combining multiple individual subject samples results in increased test accuracy over single sample testing. This approach requires validation in an independent cohort of subjects before application in the clinic.
Transbronchial Cryobiopsy in Diffuse Lung Disease: Update for the Pathologist
Colby, Thomas V. , Cavazza, Alberto , Dubini, Alessandra, Poletti, Venerino , Tomassetti, Sara

Mayo Clinic

Archives of Pathology & Laboratory Medicine | September 2, 2016 | Volume: 141 | Issue: 7 | Pages: 891-900

10.5858/arpa.2016-0233-ra | PMID 27588334 Get It

Context.— Transbronchial cryobiopsy has recently been proposed as an alternative to surgical biopsy in the diagnosis of diffuse lung disease. Objective.— To familiarize pathologists with transbronchial cryobiopsy, including what it is, how it is performed, how it compares to other techniques of lung biopsy in diffuse lung disease, what are the technical issues relating to it, what the complications are, how cryobiopsies should be interpreted, and the clinical usefulness of cryobiopsy. Data Sources.— All the available literature on cryobiopsy in diffuse lung disease through May 2016, primarily in the last 5 years, was reviewed, and some unpublished data known to the authors were included. Conclusions.— Cryobiopsies are considerably larger than forceps biopsies and allow pattern recognition approaching that of a surgical lung biopsy in many cases. Artifacts associated with cryobiopsy are minimal. In comparison with surgical lung biopsies, the diagnosis rate with cryobiopsies is lower, in the neighborhood of 80%, versus higher than 90% for surgical lung biopsies. Cryobiopsy is proposed as an alternative to surgical lung biopsy and a technique that may appreciably decrease the number of patients who require surgical lung biopsy for diagnosis. This is important because the mortality from cryobiopsy is very small (0.1% to date) compared with surgical lung biopsy (1.7% for elective procedures and considerably higher for nonelective procedures).
Total and Lectin-Binding Proteome of Spherulin from Coccidioides posadasii
Grys, Thomas E. , Kaushal, Setu, Chowdhury, Yasmynn, Dasari, Surendra , Mitchell, Natalie M., Magee, D. Mitchell, Blair, Janis E. , Colby, Thomas V. , Lake, Douglas F. , Mitchell, Natalie Michelle, Grys, Thomas E

Mayo Clinic

Journal of Proteome Research | August 22, 2016 | Volume: 15 | Issue: 10 | Pages: 3463-3472

10.1021/acs.jproteome.5b01054 | PMID 27546806 Get It

Estrogen and Progesterone Receptors in Lymphangioleiomyomatosis, Epithelioid Hemangioendothelioma, and Sclerosing Hemangioma of the Lung
Ohopj, N. Paul, Yousem, Samuel A., Sonmez-Alpan, Eni, Colby, Thomas V.

Mayo Clinic

American Journal of Clinical Pathology | March 17, 2016 | Volume: 96 | Issue: 4 | Pages: 529-535

10.1093/ajcp/96.4.529 | PMID 1716416 Get It

Bronchoscopic Lung Cryobiopsy Increases Diagnostic Confidence in the Multidisciplinary Diagnosis of Idiopathic Pulmonary Fibrosis
Tomassetti, Sara , Wells, Athol U. , Costabel, Ulrich , Cavazza, Alberto , Colby, Thomas V. , Rossi, Giulio , Sverzellati, Nicola , Carloni, Angelo, Carretta, Elisa , Buccioli, Matteo , Tantalocco, Paola, Ravaglia, Claudia , Gurioli, Christian, Dubini, Alessandra, Piciucchi, Sara , Ryu, Jay H. , Poletti, Venerino , Rossi, Antônio , Ryu, Jay H , Ravaglia, Claudia

Mayo Clinic

American Journal of Respiratory and Critical Care Medicine | November 12, 2015 | Volume: 193 | Issue: 7 | Pages: 745-752

10.1164/rccm.201504-0711oc | PMID 26562389 Get It

Abstract Rationale Surgical lung biopsy is often required for a confident multidisciplinary diagnosis of idiopathic pulmonary fibrosis (IPF). Alternative, less-invasive biopsy methods, such as bronchoscopic lung cryobiopsy (BLC), are highly desirable. Objectives To address the impact of BLC on diagnostic confidence in the multidisciplinary diagnosis of IPF. Methods In this cross-sectional study we selected 117 patients with fibrotic interstitial lung disease without a typical usual interstitial pneumonia pattern on high-resolution computed tomography. All cases underwent lung biopsies: 58 were BLC, and 59 were surgical lung biopsy (SLB). Two clinicians, two radiologists, and two pathologists sequentially reviewed clinical-radiologic findings and biopsy results, recording at each step in the process their diagnostic impressions and confidence levels. Measurements and Main Results We observed a major increase in diagnostic confidence after the addition of BLC, similar to SLB (from 29 to 63%, P = 0.0003 and from 30 to 65%, P = 0.0016 of high confidence IPF diagnosis, in the BLC group and SLB group, respectively). The overall interobserver agreement in IPF diagnosis was similar for both approaches (BLC overall kappa, 0.96; SLB overall kappa, 0.93). IPF was the most frequent diagnosis (50 and 39% in the BLC and SLB group, respectively; P = 0.23). After the addition of histopathologic information, 17% of cases in the BLC group and 19% of cases in the SLB group, mostly idiopathic nonspecific interstitial pneumonia and hypersensitivity pneumonitis, were reclassified as IPF. Conclusions BLC is a new biopsy method that has a meaningful impact on diagnostic confidence in the multidisciplinary diagnosis of interstitial lung disease and may prove useful in the diagnosis of IPF. This study provides a robust rationale for future studies investigating the diagnostic accuracy of BLC compared with SLB.
Histopathology of Disseminated Mycobacterium bovis Infection Complicating Intravesical BCG Immunotherapy for Urothelial Carcinoma
Larsen, Brandon T. , Grys, Thomas E. , Vikram, Holenarasipur R. , Colby, Thomas V. , Smith, Maxwell L. , Vikram, Holenarasipur R. , Grys, Thomas E

Mayo Clinic

International Journal of Surgical Pathology | January 23, 2015 | Volume: 23 | Issue: 3 | Pages: 189-195

10.1177/1066896914567332 | PMID 25614462 Get It

Intravesical instillation of Bacillus Calmette-Guérin (BCG) is a mainstay of adjunctive therapy for superficial bladder cancer. Disseminated BCG infection (“BCG-osis”) after this therapy is rare and potentially life-threatening; only isolated case reports detail the histopathologic findings thereof, few of which had a diagnosis confirmed by molecular testing. We report 3 additional cases of BCG-osis complicating BCG therapy, all confirmed by cultures and molecular assays, including the first cases of wedge biopsy-confirmed BCG pneumonia and BCG olecranon bursitis. When suggested by a relevant clinical history, recognition of randomly distributed granulomas in any organ should prompt consideration of BCG-osis and liberal performance of AFB stains, aided by targeted molecular assays. Physicians should maintain a high index of suspicion when miliary infiltrates arise after intravesical BCG instillation, and close multidisciplinary communication is essential. Pathologist awareness of this rare cause of granulomatous inflammation aids recognition of BCG-osis and facilitates prompt initiation of antimycobacterial therapy.
Pulmonary pyoderma gangrenosum without cutaneous manifestations
Sakata, Kenneth K. , Penupolu, Sudheer, Colby, Thomas V. , Wesselius, Lewis , Sakata, Kenneth Kazuto, Colby, Thomas Vail, Gotway, Michael Bruce, Wesselius, Lewis Jon, Gotway, Michael B.

Mayo Clinic

The Clinical Respiratory Journal | October 30, 2014 | Volume: 10 | Issue: 4 | Pages: 508-511

10.1111/crj.12240 | PMID 25354722 Get It

AbstractPyoderma gangrenosum is a chronic sterile skin disorder that is frequently seen in association with systemic disorders such as inflammatory bowel disease. Extracutaneous pyoderma gangrenosum is rare and most commonly occurs in the lungs. It is particularly unusual for extracutaneous pyoderma gangrenosum to manifest prior to skin findings and without an associated systemic disorder. A 19‐year‐old white man presented with shortness of breath and a productive cough. His skin exam was normal. Unenhanced chest computed tomography showed peripheral consolidations, areas of cavitation, nodules and bilateral pleural effusions. A bronchoalveolar lavage and an autoimmune panel were unremarkable. Right lung wedge biopsies via thoracostomy was performed and showed pulmonary pyoderma gangrenosum. He was treated with corticosteroids and has returned back to his baseline. This is the first case of pulmonary pyoderma gangrenosum without any associated underlying systemic disorder and without any cutaneous manifestations to date. Serial follow‐ups are necessary to assess for the development of an associated systemic disorder or skin lesions.
Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease
Diamond, Eli L. , Dagna, Lorenzo , Hyman, David M. , Cavalli, Giulio , Jankú, Filip , Estrada‐Veras, Juvianee , Ferrarini, Marina , Abdel‐Wahab, Omar , Heaney, Mark , Feeley, Nancy , McClain, Kenneth L. , Vaglio, Augusto , Colby, Thomas V. , Arnaud, Laurent , Haroche, Julien , Colby, Thomas, Scheel, Paul J. , Ferrero, Elisabetta , Diamond, Eli L , Abdel-Wahab, Omar , McClain, Kenneth L , Vaglio, Augusto

Mayo Clinic

Blood | May 22, 2014 | Volume: 124 | Issue: 4 | Pages: 483-492

10.1182/blood-2014-03-561381 | PMID 24850756 Get It

Abstract Erdheim-Chester disease (ECD) is a rare, non-Langerhans histiocytosis. Recent findings suggest that ECD is a clonal disorder, marked by recurrent BRAFV600E mutations in >50% of patients, in which chronic uncontrolled inflammation is an important mediator of disease pathogenesis. Although ∼500 to 550 cases have been described in the literature to date, increased physician awareness has driven a dramatic increase in ECD diagnoses over the last decade. ECD frequently involves multiple organ systems and has historically lacked effective therapies. Given the protean clinical manifestations and the lack of a consensus-derived approach for the management of ECD, we provide here the first multidisciplinary consensus guidelines for the clinical management of ECD. These recommendations were outlined at the First International Medical Symposium for ECD, comprised of a comprehensive group of international academicians with expertise in the pathophysiology and therapy of ECD. Detailed recommendations on the initial clinical, laboratory, and radiographic assessment of ECD patients are presented in addition to treatment recommendations based on critical appraisal of the literature and clinical experience. These formalized consensus descriptions will hopefully facilitate ongoing and future research efforts in this disorder.
Perplexing Lesions of the Sinonasal Cavity and Skull Base: IgG4‐related and Similar Inflammatory Diseases
Cain, Rachel B. , Colby, Thomas V. , Balan, Vijayan , Patel, Naresh P. , Lal, Devyani , Patel, Naresh P

Mayo Clinic

Otolaryngology–Head and Neck Surgery | May 9, 2014 | Volume: 151 | Issue: 3 | Pages: 496-502

10.1177/0194599814533648 | PMID 24812077 Get It

ObjectiveIgG4‐related disease (IgG4RD) causing sinonasal and skull base pathology is uncommonly described. We present a series of suspected IgG4RD patients, with a pertinent review of the literature to highlight diagnostic challenges.Study DesignCase series.SettingAcademic tertiary care center.Subjects and MethodsCase series of patients with IgG4RD or suspected IgG4RD involving the sinonasal cavity and skull base.ResultsWe present 4 patients with atypical sinonasal and/or skull base disease who were noted to have IgG4‐positive plasma cell infiltration on immunohistochemistry of biopsy specimens. IgG4RD, a recently described entity affecting multiple organs, is characterized by lymphoplasmacytic infiltration and often elevated serum IgG4. IgG4RD can masquerade as malignancy or infection but responds to glucocorticosteroid and immunosuppressant therapy. IgG4RD has been infrequently reported presenting as sinonasal or skull base lesions, and definitive diagnostic criteria for these regions are not established. In our series, IgG4RD was suspected in all 4 patients, but only 1 met all current criteria for definitive diagnosis. All 4 patients, however, responded to corticosteroid therapy, and 1 was placed on long‐term azathioprine.ConclusionIgG4RD is rarely described in the sinonasal cavity and skull base, and specific diagnostic criteria for such disease have not been defined. We present a series of patients with IgG4‐positive plasma cell inflammatory pathology who were suspected to have IgG4RD. Our series highlights diagnostic challenges associated with these patients. Tumefactive and destructive sinonasal‐skull base lesions with a plasma cell‐rich infiltrate should incite suspicion of IgG4RD, and immunohistochemistry for IgG4‐positive plasma cells should be performed.